ArriVent BioPharma, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
AVBP on Nasdaq
Location
18 Campus Blvd., Suite 100, Newtown Square, PA

There are no Buy or Sell transactions made by insiders since 11/5/2023

ArriVent BioPharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hillhouse Investment Management, Ltd. 10%+ Owner $16.4M Jan 30, 2024
James Healy Director $6.19M Jan 30, 2024
Carl L. Gordon Director, 10%+ Owner $5.52M Jan 30, 2024
Orbimed Advisors Llc Director, 10%+ Owner $5.52M Jan 30, 2024
Zhengbin Yao President and CEO, Director $2.24M Jan 25, 2024
Robin LaChapelle Chief Operating Officer $1.89M Sep 19, 2024
Stuart Lutzker President of R&D, Director $539K Jan 25, 2024
James Paul Kastenmayer General Counsel $27K Jan 25, 2024
Kristine Peterson Director Apr 22, 2024
Winston Kung Chief Financial Officer Jan 25, 2024
Chris Nolet Director Jan 25, 2024
Bahija Jallal Director Jan 25, 2024
John Hohneker Director May 16, 2024

Recent Insider Transactions by Companies or Individuals for ArriVent BioPharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.